Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Health claims

Health claims

Functional foods and supplements are as successful as the claims they can make. But new health claim regulations in Europe, and a tightening regulatory environment in the US can make it hard to know how messages must be communicated without overstepping the line.

Scientists protest as EC validates omega-3 labelling rule

The group of international scientists that last week petitioned the European Commission to amend a mooted omega-3 labelling regulation they believe would confuse consumers, have vowed to continue their fight...

Yoghurt group unfazed by mass probiotics rejection

The European Food Safety Authority’s mass rejection of probiotic dossiers is not the disaster it appears if ‘technical’ obstacles can be overcome, according to a group that represents the biggest...

Consumer press highlights probiotic health claim failures

Last week’s European Food Safety Authority (EFSA) health claim opinions have received a lot of mainstream media attention in the UK national consumer press, with the probiotic claim rejections gaining...

Comment

Bad day at the EU health claims office

October 1 was not a good day for many in the functional foods and food supplements business in the European Union as the meaning of life under a highly restrictive...

Devil not so bad in EFSA health claim details

At first glance yesterday’s publication of the first batch of 94 article 13.1 health claim opinions, is a worst-case scenario for industry, with claims for the likes of omega-3s, beta-glucan,...

Article 13.1: winners and losers

Botanicals, probiotics and weight management claims were the big losers in yesterday’s first batch of article 13.1 claims, with not a positive opinion among them.

EFSA health claim opinion

EFSA says yes to third of first Article 13.1 claims

Around one third of the first batch of article 13.1 health claim applications have drawn positive opinions from EFSA. Professor Albert Flynn, the head of EFSA’s health claims assessment panel,...

Scientists unite to stop omega-3 ‘Euro-mad rush’

Twenty one of the world’s leading omega-3 scientists have petitioned the European Commission in a last-ditch effort to convince EU rule makers its omega-3 nutrition labelling plans are flawed and...

Exclusive interview

How tomatoes are informing Danone's probiotic claims

Danone’s newly submitted article 14 probiotic, diarrhoea health claim, is a product of the ongoing learning process that is occurring as companies come to grips with the reality of the...

Special edition: Brain health

Regulation: Communicating cognitive health

In the sixth article in our series on brain health, regulations governing the area are explored.

Ultra-sensitive nutrient assays to boost health claim dossiers

UK-based third party testing service, HFL Sports Science, has developed a series of ultra-sensitive lab assays that will allow supplements and functional food manufacturers to more accurately measure molecular profiles...

Special edition: Brain health

Supply: The back-end of brain health

In the third article in this brain health series, we break down some of the key ingredients in the sector.

Danone to resubmit bolstered article 13.5 dossiers

Danone will resubmit withdrawn article 13.5 European Union probiotic health claims by year’s end with additional trials added to the dossiers to strengthen their claims, according to a health claims...

Codex can unite Asian food regulations

The importance of the Codex Alimentaria in developing regulatory harmony in a region like Asia where rules differ so greatly, has been emphasised at a recent event hosted by the...

Comment

Are health claims curbing freedom of speech?

The US FDA is being sued over its health claims regime – actions that are unlikely to succeed according to most pundits – but they raise serious questions about healthy...

Special edition: Market insights

F&S: The danger of overstepping health claim boundaries

Health claim confusion has never been greater as industry adjusts to the new European health claims process. As part of a NutraIngredients series canvassing analyst insights, market researcher Frost &...

Danone re-enters EU probiotic health claim game

Global probiotics leader, Danone, has submitted a new disease reduction article 14 health claim linking consumption of its probiotic drinking yoghurt, Actimel, and diarrhoea, after withdrawing three article 13.5 immunity...

Special edition: Market insights

Mintel: Preparing for a functional foods turnaround

The intrinsic health benefits of foods are likely to become a key focus of functional food growth in Europe as industry prepares for a major shift in the coming year....

Health claims focus

European Union health claims: where to now?

By this time next year, one of the central ambitions of Europe’s brand-spanking new nutrition and health claims system may well be in place – a centralised list of approved...

Health claims focus

Inside Europe’s health claim conundrum

In the third part of this European health claims series we examine some of the key decisions to see where companies have got it wrong – and right.

Health claims focus

The evolution of Europe’s health claims system

In part two of a series on the European nutrition and health claims regulation, we take a look into the past to scrutinize the reasons for its inception and wonder...

Health claims focus

Timeline of key EU health claim opinions

In the first of a special four-part series, NutraIngredients constructs a timeline of key opinions issued by the European Food Safety Authority (EFSA) since it got the ball rolling back...

World first probiotic 100% juice launched

Swedish dairy pioneer, Skånemejerier, has extended its Scandinavian-leading juice range, Bravo, to incorporate probiotic strains, believed to be the first in the world to do so in a fresh 100...

Austrian supplements infringe isoflavones patent

An Austrian court has ruled against a red clover food supplement for making misleading menopausal claims in breach of a European health indications patent held by the Australian firm, Novogen.

Rosehip extract censored over bone health claims

UK supplements company, Goldshield Healthcare Direct, has run foul of the advertising watchdog there for making misleading joint health claims in full-page national newspaper adverts about a rosehip extract.